SILK ROAD MEDICAL INC (SILK)
US82710M1009 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 22.63M | 20.21M | 55.40M | 110.20M | 69.50M | |||
| Marketable Securities | 151.83M | 161.26M | 158.30M | 0.00 | 78.00M | |||
| Receivables | 27.20M | 23.57M | 18.00M | 11.80M | 9.10M | |||
| Inventories | 30.49M | 29.88M | 19.30M | 17.90M | 10.00M | |||
| Other Current Assets | 3.54M | 5.91M | 3.90M | 3.40M | 6.80M | |||
| Total Current Assets | 235.69M | 240.84M | 254.90M | 143.30M | 173.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 8.09M | 14.60M | 14.50M | 12.90M | 5.60M | |||
| Investments And Advances | 2.03M | 9.46M | N/A | N/A | 0.00 | |||
| Other Non-Current Assets | 6.51M | 415.00K | 300.00K | 400.00K | 300.00K | |||
| Total Non-Current Assets | 16.62M | 24.47M | 14.80M | 13.30M | 6.00M | |||
| TOTAL ASSETS | 252.31M | 265.31M | 269.70M | 156.60M | 179.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | N/A | 0.00 | 0.00 | 3.90M | 0.00 | |||
| Accrued Expenses | 18.37M | 24.46M | 21.70M | 19.60M | 16.80M | |||
| Accounts Payable | 2.97M | 5.68M | 2.50M | 2.40M | 2.60M | |||
| Other Current Liabilities | N/A | 143.00K | 300.00K | 200.00K | 200.00K | |||
| Total Current Liabilities | 21.34M | 30.28M | 24.50M | 26.10M | 19.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 75.89M | 75.63M | 74.60M | 44.80M | 48.50M | |||
| Other Non-Current Liabilities | 7.81M | 8.25M | 6.70M | 6.50M | 3.70M | |||
| Total Non-Current Liabilities | 83.69M | 83.88M | 81.30M | 51.30M | 52.20M | |||
| TOTAL LIABILITIES | 105.03M | 114.16M | 105.80M | 77.40M | 71.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -413.59M | -399.45M | -343.70M | -288.70M | -238.90M | |||
| Additional Paid In Capital | 560.85M | 550.50M | 507.70M | 367.90M | 346.30M | |||
| Minority Interest | N/A | N/A | N/A | N/A | 0.00 | |||
| Common Shares | 39.00K | 39.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -17.00K | 72.00K | -200.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 39.44M | 39.17M | 38.40M | 35.00M | 34.20M | |||
| Tangible Book Value per Share | 3.73 | 3.86 | 4.27 | 2.26 | 3.14 | |||
| Total Shareholders' Equity | 147.28M | 151.15M | 163.90M | 79.20M | 107.50M | |||
| TOTAL LIABILITIES AND EQUITY | 252.31M | 265.31M | 269.70M | 156.60M | 179.30M | |||
| Statistics | ||||||||
| Debt/Equity | 0.52 | 0.50 | 0.46 | 0.61 | 0.45 | |||
| Current Ratio | 11.05 | 7.95 | 10.40 | 5.49 | 8.84 | |||
| Return On Assets (ROA) | -21.17% | -21.01% | -20.39% | -31.80% | -26.44% | |||
| Return On Equity (ROE) | -36.27% | -36.88% | -33.56% | -62.88% | -44.09% | |||
All data in USD